Biosciences Shift SRL
The score of Biosciences Shift shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +113 % Total assets +123 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biosciences Shift's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 32,894 € | ||||
| Equity | 185,142 € | ||||
| Cash | 19,185 € | ||||
| EBITDA | 48,863 € | ||||
| Total assets | 214,228 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 23 May 2024
- Year ended 31 Dec 2022filed on 15 May 2023
- Year ended 31 Dec 2021filed on 16 May 2022
Biosciences Shift's financial analysis
- Solvency86.4%sector median: 26.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biosciences Shift
Biosciences Shift's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0840.325.153
- VAT number
- BE0840325153
- Peppol
- Registered · 0208:0840325153 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Oct 2011
- Registered office
- 7382 Quiévrain
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of cosmetic and toilet articles (NACE 47750)
Biosciences Shift (SRL) has been based in Quiévrain since 2011, active in: retail sale of cosmetic and toilet articles. For 2025, it reports a net profit of 32,894 € and equity of 185,142 €; its revenue is not published. Its solvency stands at 86.4%, above the median of its sector (26.6%).
Companies similar to Biosciences Shift
Companies in the same business, of comparable size and area, outside its group.
- Olfastyle Manufacture of soap and detergents, cleaning and polishing preparations Ixelles · balance sheet 94,422 €
- LUMIscience Manufacture of perfume and toilet preparations Koksijde · balance sheet 63,645 €
- L'Escapade Beauté de Laura H. Retail sale of cosmetic and toilet articles Arlon · balance sheet 214,629 €
- D&S Esthetic Retail sale of cosmetic and toilet articles Wemmel · balance sheet 72,122 €
- Qonia Retail sale of cosmetic and toilet articles Brussels · balance sheet 173,042 €
- BougiGroup Retail sale of cosmetic and toilet articles Beveren-Kruibeke-Zwijndrecht · balance sheet 312,792 €
- Aamal Europe Investment Retail sale of cosmetic and toilet articles Machelen (Brab.) · balance sheet 211,946 €
- Mospanco Belgium Retail sale of cosmetic and toilet articles Brussels · balance sheet 125,408 €
Frequently asked questions about Biosciences Shift
What is the revenue of Biosciences Shift?
Biosciences Shift files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biosciences Shift?
In Belgium, the VAT number is the company number prefixed with BE: BE0840325153 for Biosciences Shift, if the company is VAT-registered. Its company number (CBE) is 0840.325.153.
Where is the registered office of Biosciences Shift?
According to the CBE register, the registered office of Biosciences Shift is in 7382 Quiévrain.
What is the equity of Biosciences Shift?
At the close of the 2025 financial year, the equity of Biosciences Shift amounts to 185,142 €, a solvency of 86.4% of total assets.
Who manages Biosciences Shift?
The register lists 1 active mandates at Biosciences Shift. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biosciences Shift
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →